Short description
BioIntervene is engages in drug discovery and development.
Description
BioIntervene is a preclinical-stage biopharmaceutical company committed to the discovery and development of effective and non-addictive medicines for chronic pain and other chronic inflammatory and neurodegenerative disorders. The Company was founded in 2014 based on insights from research at Saint Louis University and the National Institutes of Health (NIH). BioIntervene’s founding team has pioneered the understanding of adenosine A3 receptor biology, with a focus on developing first-in-class, selective adenosine A3 receptor agonists.
Total funding
$$121212
Sign in for full access
Location
San Diego, California, United States, North America
Founded on
January 1, 2014
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$56378 - 90123
Sign in for full access
Investors
Uh Ohhhh
Sign in for full access
Founders
Daniela Salvemini, Gary Bennett